Development of an Algorithm for Identification of Responders to Short Term Treatment With Esomeprazole (Nexium) in Primary Care.

Trial Profile

Development of an Algorithm for Identification of Responders to Short Term Treatment With Esomeprazole (Nexium) in Primary Care.

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Oct 2010

At a glance

  • Drugs Esomeprazole (Primary)
  • Indications Dyspepsia; Gastro-oesophageal reflux
  • Focus Therapeutic Use
  • Acronyms RESPONSE
  • Sponsors AstraZeneca
  • Most Recent Events

    • 27 Oct 2009 Secondary endpoint results presented at the 12th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
    • 03 Feb 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top